Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Director Acquires $1,298,492.50 in Stock

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) Director Eric Andersen bought 101,050 shares of the company’s stock in a transaction that occurred on Thursday, December 7th. The stock was bought at an average cost of $12.85 per share, for a total transaction of $1,298,492.50. Following the completion of the transaction, the director now directly […]

Related Keywords

Massachusetts ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Eric Andersen ,News Ratings For Merrimack Pharmaceuticals Daily ,Merrimack Pharmaceuticals ,Quarter For Merrimack Pharmaceuticals ,Merrimack Pharmaceuticals Inc ,Wittenberg Investment Management Inc ,Merrimack Pharmaceuticals Trading ,Nasdaq ,Hedge Funds Weigh In On Merrimack Pharmaceuticals ,Kennedy Capital Management ,Get Free Report ,Director Eric Andersen ,Capital Management ,Investment Management ,Sepio Capital ,Merrimack Pharmaceuticals Daily ,Nasdaq Mack ,Smack ,Medical ,59032810 ,Insider Trading ,Nsider Trades ,Stocks ,